Alexia Rivero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexia Rivero has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Cédric Polesello
MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse UT, Toulouse, France
2 shared publications - François Payre
Molecular, Cellular and Developmental Biology Department (MCD), Centre de Biologie Intégrative (CBI), CNRS, UPS, University of Toulouse
2 shared publications - Adeline Payet
Center for Integrative Biology, Molecular Cellular and Developmental (MCD) Biology Unit, Federal University of Toulouse, Toulouse, France
1 shared publication Alexandra Mancheno-Ferris
Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS
1 shared publication- Clément Immarigeon
Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS
1 shared publication - Coralie Sengenès
University of Toulouse, CNRS UMR 5070, INSERM U1301, EFS, ENVT, Institut RESTORE, Toulouse, France
1 shared publication
Latest Publications
- Open Access
Cancer cachexia overrides sex-specific traits in Drosophila
Cancer cachexia, a metabolic syndrome characterized by pathologic weight loss, dramatically limits therapeutic options and reduces survival. While the mechanisms by which tumors induce wasting of distant organs (particularly muscle and adipose tissues) remain incompletely understood, the influence of biological sex on cachexia progression is even less clear. Here we investigated phenotypic and molecular manifestations of cachexia in both sexes using a model of inducible intestinal tumors in Drosophila . We show that tumor progression leads to the development of severe cachexia both in males and in females manifested by organ atrophies and an inflammatory state. Nevertheless, both phenotypical and molecular cachexic alterations exhibit striking differences between sexes. Transcriptomic analysis show that many genes differentially expressed at high levels in males under normal conditions become downregulated during cachexia, while their expression is upregulated in cachexic females, and reciprocally. Together, sex-specific deregulation in gene expression and metabolic profiles ultimately converge towards a molecular cachexic state that erase or diminish many sex-specific differences otherwise characteristic of healthy males and females. These findings highlight the interplay between oncogenic stress and biological sex in shaping cachexia phenotypes, shedding light on how sex influences the development of cancer cachexia.
Open AccessCancer cachexia overrides sex-specific traits in Drosophila
Cancer cachexia, a metabolic syndrome characterized by pathologic weight loss, dramatically limits therapeutic options and reduces survival. While the mechanisms by which tumors induce wasting of distant organs (particularly muscle and adipose tissues) remain incompletely understood, the influence of biological sex on cachexia progression is even less clear. Here we investigated phenotypic and molecular manifestations of cachexia in both sexes using a model of inducible intestinal tumors in Drosophila . We show that tumor progression leads to the development of severe cachexia both in males and in females manifested by organ atrophies and an inflammatory state. Nevertheless, both phenotypical and molecular cachexic alterations exhibit striking differences between sexes. Transcriptomic analysis show that many genes differentially expressed at high levels in males under normal conditions become downregulated during cachexia, while their expression is upregulated in cachexic females, and reciprocally. Together, sex-specific deregulation in gene expression and metabolic profiles ultimately converge towards a molecular cachexic state that erase or diminish many sex-specific differences otherwise characteristic of healthy males and females. These findings highlight the interplay between oncogenic stress and biological sex in shaping cachexia phenotypes, shedding light on how sex influences the development of cancer cachexia.
- Open Access
The Mediator complex subunit Med19 extends healthy lifespan in Drosophila by preventing cellular and organismal frailty
Aging involves a progressive decline in physiological functions, often marked by the onset of a “frailty point” just before survival rates decrease rapidly. Here, we investigate how the Mediator subunit Med19 modulates this transition in Drosophila . We find that upregulating Med19 extends the median lifespan by nearly 90% and postpones the onset of accelerated mortality, suggesting that Med19 helps preserve the resilience phase of aging. In contrast, Med19 downregulation sharply reduces both median and maximum lifespan, advancing the frailty threshold. We show that Med19 knockdown increases fly vulnerability to environmental insults such as oxidative and genotoxic challenges whereas Med19 upregulation helps them resist these stresses, underscoring Med19’s protective role in maintaining genomic integrity. We link these phenotypes to altered stress-response pathways at the cellular level: Med19-depleted cells show a compensatory upregulation of genes involved in iron–sulfur cluster biogenesis, glutathione metabolism, and DNA damage repair. At the cellular level, Med19 depletion triggers a “loser” phenotype in cell competition assays, activating the JNK pathway and undergoing apoptosis, highlighting a form of “cellular frailty” that parallels organismal frailty. Finally, we found that the Med19 protein level naturally decreases with age and showed that restoring Med19 expression in aged flies increases fitness and delays the onset of frailty even in older, “frail” individuals, underscoring its significance as an aging regulator. Altogether, our findings establish Med19 as a crucial mediator of lifespan and stress resilience, suggesting it acts as a rheostat that modulates the transition from healthy aging to frailty in Drosophila . GRAPHICAL Highlights: - At the organismal level, Med19 upregulation extends Drosophila lifespan by 90%, delays the onset of frailty and enhances oxidative and DNA damage stress resistance, while its depletion has the opposite effect. - Med19 depletion alters the expression of stress response genes and induces a loser-cell phenotype in cell competition assays revealing its crucial function in controlling cellular fitness. - Med19 protein levels naturally decline with age, and its restoration in aged flies improves both healthspan and lifespan.
Open AccessThe Mediator complex subunit Med19 extends healthy lifespan in Drosophila by preventing cellular and organismal frailty
Aging involves a progressive decline in physiological functions, often marked by the onset of a “frailty point” just before survival rates decrease rapidly. Here, we investigate how the Mediator subunit Med19 modulates this transition in Drosophila . We find that upregulating Med19 extends the median lifespan by nearly 90% and postpones the onset of accelerated mortality, suggesting that Med19 helps preserve the resilience phase of aging. In contrast, Med19 downregulation sharply reduces both median and maximum lifespan, advancing the frailty threshold. We show that Med19 knockdown increases fly vulnerability to environmental insults such as oxidative and genotoxic challenges whereas Med19 upregulation helps them resist these stresses, underscoring Med19’s protective role in maintaining genomic integrity. We link these phenotypes to altered stress-response pathways at the cellular level: Med19-depleted cells show a compensatory upregulation of genes involved in iron–sulfur cluster biogenesis, glutathione metabolism, and DNA damage repair. At the cellular level, Med19 depletion triggers a “loser” phenotype in cell competition assays, activating the JNK pathway and undergoing apoptosis, highlighting a form of “cellular frailty” that parallels organismal frailty. Finally, we found that the Med19 protein level naturally decreases with age and showed that restoring Med19 expression in aged flies increases fitness and delays the onset of frailty even in older, “frail” individuals, underscoring its significance as an aging regulator. Altogether, our findings establish Med19 as a crucial mediator of lifespan and stress resilience, suggesting it acts as a rheostat that modulates the transition from healthy aging to frailty in Drosophila . GRAPHICAL Highlights: - At the organismal level, Med19 upregulation extends Drosophila lifespan by 90%, delays the onset of frailty and enhances oxidative and DNA damage stress resistance, while its depletion has the opposite effect. - Med19 depletion alters the expression of stress response genes and induces a loser-cell phenotype in cell competition assays revealing its crucial function in controlling cellular fitness. - Med19 protein levels naturally decline with age, and its restoration in aged flies improves both healthspan and lifespan.
- Open Access
Crosstalk between chromatin and the transcription factor Shavenbaby defines transcriptional output along the Drosophila intestinal stem cell lineage
Summary: The transcription factor Shavenbaby (Svb), the only member of the OvoL family in Drosophila , controls intestinal stem cell differentiation. Post-translational modification of Svb produces two protein isoforms, Svb-ACT and Svb-REP, which promote intestinal stem cell renewal or differentiation, respectively. Using engineered cell lines, we express either isoform to define their mode of action, and develop an unbiased method to identify Svb target genes in intestinal cells. Within a given cell type, Svb-ACT and Svb-REP antagonistically regulate the expression of a set of target genes, binding specific enhancers whose accessibility is constrained by. During intestinal differentiation, the set of target genes progressively changes, together with chromatin accessibility. Moreover, Svb-REP binding stabilizes three-dimensional enhancer-promoter loops, while influencing the local chromatin landscape to repress target genes. We propose that SvbACT-to-REP switch promotes enterocyte differentiation of intestinal stem cells through direct gene regulation and chromatin remodeling.
Open AccessCrosstalk between chromatin and the transcription factor Shavenbaby defines transcriptional output along the Drosophila intestinal stem cell lineage
Summary: The transcription factor Shavenbaby (Svb), the only member of the OvoL family in Drosophila , controls intestinal stem cell differentiation. Post-translational modification of Svb produces two protein isoforms, Svb-ACT and Svb-REP, which promote intestinal stem cell renewal or differentiation, respectively. Using engineered cell lines, we express either isoform to define their mode of action, and develop an unbiased method to identify Svb target genes in intestinal cells. Within a given cell type, Svb-ACT and Svb-REP antagonistically regulate the expression of a set of target genes, binding specific enhancers whose accessibility is constrained by. During intestinal differentiation, the set of target genes progressively changes, together with chromatin accessibility. Moreover, Svb-REP binding stabilizes three-dimensional enhancer-promoter loops, while influencing the local chromatin landscape to repress target genes. We propose that SvbACT-to-REP switch promotes enterocyte differentiation of intestinal stem cells through direct gene regulation and chromatin remodeling.